Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

9.6K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
9.6K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

7.2K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
7.2K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

6.9K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sézary syndrome.

British journal of haematology·2026
Same author

Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group.

The Journal of allergy and clinical immunology·2026
Same author

Clinical Validation of Imaging Biomarkers in Mycosis Fungoides.

Experimental dermatology·2026
Same author

Progression of mycosis fungoides in a patient receiving a Janus kinase inhibitor.

JAAD case reports·2025
Same author

Mycosis Fungoides Palmaris et Plantaris.

JAMA dermatology·2025
Same author

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.

The British journal of dermatology·2025

Related Experiment Video

Updated: May 3, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.2K

Recent advances in primary cutaneous B-cell lymphomas.

Maarten H Vermeer1, Rein Willemze

  • 1Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.

Current Opinion in Oncology
|January 28, 2014
PubMed
Summary

Advances in primary cutaneous B-cell lymphomas (CBCLs) classification, staging, and treatment have improved patient care. New molecular studies and therapies show promise for specific CBCL subtypes.

More Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

1.0K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.3K

Related Experiment Videos

Last Updated: May 3, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.2K
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

1.0K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

26.3K

Area of Science:

  • Dermatology
  • Hematology
  • Oncology

Background:

  • Debate on primary cutaneous B-cell lymphomas (CBCLs) classification and terminology has persisted.
  • The WHO-EORTC classification established three main CBCL types: primary cutaneous marginal zone B-cell lymphoma (PCMZL), primary cutaneous follicle centre lymphoma (PCFCL), and primary cutaneous large B-cell lymphoma, leg type (PCLBCL, LT).

Purpose of the Study:

  • To review the classification, staging, and treatment of primary cutaneous B-cell lymphomas (CBCLs).
  • To highlight the clinical relevance and reproducibility of the WHO-EORTC classification for CBCLs.

Main Methods:

  • Epidemiological studies on patient cohorts.
  • Collaborative studies between the International Society for Cutaneous Lymphomas (ISCL) and the EORTC Lymphoma Group.
  • Review of recent therapeutic studies.

Main Results:

  • The WHO-EORTC classification and the 4th WHO classification are reproducible and clinically relevant worldwide.
  • Recommended staging procedures and consensus treatment guidelines for CBCL subtypes have been established.
  • Intralesional/intravenous rituximab shows therapeutic value in PCFCL and PCMZL.
  • Targeting the NF-kB pathway may benefit DLBCL, LT.

Conclusions:

  • Advances in CBCL classification, staging, and treatment have significantly improved clinical care.
  • Standardized classification facilitates molecular research and treatment comparison.
  • Rituximab and NF-kB pathway inhibitors represent promising therapeutic avenues for specific CBCL subtypes.